Hepatocellular Carcinoma Clinical Trials in Montpellier
5 recruitingMontpellier, France
Showing 1–5 of 5 trials
Recruiting
Phase 2
Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma
Centre Hospitalier Universitaire de Besancon105 enrolled14 locationsNCT05528952
Recruiting
Phase 2
Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
Liver TransplantHepatocellular Carcinoma RecurrentSystemic Treatment
Assistance Publique - Hôpitaux de Paris50 enrolled10 locationsNCT06254248
Recruiting
Phase 2Phase 3
Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma
Hepatocellular Carcinoma
UNICANCER196 enrolled11 locationsNCT06904170
Recruiting
Phase 2
Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial
Hepatocellular Carcinoma
University Hospital, Montpellier202 enrolled19 locationsNCT04727307
Recruiting
Not Applicable
Liver Cancer and Immunotherapy in the Liquid Biopsy Era
Hepatocellular CarcinomaImmune Checkpoint InhibitorLiquid Biopsy+2 more
University Hospital, Montpellier60 enrolled1 locationNCT05810402